Followers | 22 |
Posts | 4027 |
Boards Moderated | 1 |
Alias Born | 08/18/2017 |
Friday, January 29, 2021 12:03:17 PM
Fundamental Research analyst Siddharth Rajeev initiated coverage with a Buy rating on THC Biomed INTL (THCBF) on January 15 and set a price target of C$0.22. The company’s shares closed last Wednesday at $0.11.
Rajeev has an average return of 2.8% when recommending THC Biomed INTL.
According to TipRanks.com, Rajeev is ranked #6674 out of 7245 analysts.
Currently, the analyst consensus on THC Biomed INTL is a Moderate Buy with an average price target of $0.17.
The company has a one-year high of $0.18 and a one-year low of $0.05. Currently, THC Biomed INTL has an average volume of 82.16K.
THC BioMed International Ltd. engages in the research, development, and cultivation of medical cannabis. It offers horticulture training, record keeping and documenting, research studies, and analytical services. The company was founded on February 2, 1982 and is headquartered in Kelowna, Canada.
https://www.smarteranalyst.com/new-blurbs/fundamental-research-initiates-a-buy-rating-on-thc-biomed-intl-thcbf/
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM